Stimulated tyrosine phosphorylation of phosphatidylinositol 3-kinase causes acidic pH-induced contraction in spontaneously hypertensive rat aorta

Journal of Pharmacology and Experimental Therapeutics

Volumn 303, Issue 3, 2002, Pages 1255-1264

  Kumar Rohra, Dileep ^a   Yamakuni, Tohru ^a   Furukawa, Ken Ichi ^b   Ishii, Noe ^a   Shinkawa, Takashi ^c   Isobe, Toshiaki ^c   Ohizumi, Yasushi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; COLLAGEN; ENZYME ANTIBODY; FIBRONECTIN; GENISTEIN; MYOSIN LIGHT CHAIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROCOLLAGEN; PROTEIN ANTIBODY; PROTEIN P85; PROTEIN TYROSINE KINASE INHIBITOR; SILVER; TYROSINE; TYRPHOSTIN; WORTMANNIN;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME PHOSPHORYLATION; ESSENTIAL HYPERTENSION; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOLECULAR SIZE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; RAT; RAT STRAIN; STRAIN DIFFERENCE; TENSION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; AORTA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HYDROGEN-ION CONCENTRATION; HYPERTENSION; MALE; PHOSPHORYLATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, WISTAR; SPECIES SPECIFICITY; TYROSINE; VASOCONSTRICTION;

EID: 0036897468     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.041475     Document Type: Article

References (37)

1. Adam LP, Franklin MT, Raff GJ, and Hathaway DR (1995) Activation of mitogen-activated protein kinase in porcine carotid arteries. Circ Res 76:183-190.
2. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, and Fukami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595.
3. 2A receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle. J Pharmacol Exp Ther 291:1179-1187.
4. Begum N, Duddy N, Sandu O, Reinzie J, and Ragolia L (2000) Regulation of myosin-bound protein phosphatase by insulin in vascular smooth muscle cells: Evaluation of the role of Rho kinase and phosphatidylinositol-3-kinase-dependent signaling pathways. Mol Endocrinol 14:1365-1376.
5. Bouillier H, Samain E, Rücker-Martin C, Renaud JF, Safar M, and Dagher G (2001) Effect of extracellular matrix elements on angiotensin II-induced calcium release in vascular smooth muscle cells from normotensive and hypertensive rats. Hypertension 37:1465-1472.
6. Butwell NA, Ramasamy R, Lazar I, Sherry AD, and Malloy CR (1993) Effect of lidocaine on contracture, intracellular sodium and pH in ischaemic rat hearts. Am J Physiol 264:H1884-H1889.
7. Carmines PK, Fallet RW, Che Q, and Fujiwara K (2001) Tyrosine kinase involvement in renal arteriolar constrictor responses to angiotensin II. Hypertension 37:569-573.
8. +-induced swine carotid artery contraction. Hypertension 25:482-489.
9. 2+ sensitivity for contraction of smooth muscle. Can J Physiol Pharmacol 72:1434-1439.
10. Di Salvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, and Pfitzer G (1993) Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem Biophys Res Commun 190:968-974.
11. Furukawa KL, Komaba J, Sakai H, and Ohizumi Y (1996) The mechanism of acidic pH induced contraction in aortae from SHR and WKY rats enhanced by increasing blood pressure. Br J Pharmacol 118:485-492.
12. Horowitz A, Menice CB, Laporte R, and Morgan KG (1996) Mechanism of smooth muscle contraction. Physiol Rev 76:967-1003.
13. Huang C, Liu J, Haudenschild CC, and Zhan X (1998) The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J Biol Chem 273:25770-25776.
14. Jin N, Siddiqui RA, English D, and Rhoades RA (1996) Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle. Am J Physiol 271:H1348-H1355.
15. Karaki H (1987) Use of tension measurements to delineate the mode of action of vasodilators. J Pharmacol Methods 18:1-21.
16. Khalil RA, Menice CB, Wang CLA, and Morgan KG (1995) Phosphotyrosine-dependent targeting of mitogen-activated protein kinase in differentiated contractile vascular cells. Circ Res 76:1101-1108.
17. 2+ sensitivity of contractile elements in intact ferret myocardium. Am J Physiol 274:H147-H154.
18. 2+ release and entry during contraction elicited by norepinephrine in rat resistance arteries. Am J Physiol 276:H300-H308.
19. Laniyonu AA, Saifeddine M, Yang SG, and Hollenberg MD (1994) Tyrosine kinase inhibitors and the contractile action of G-protein linked vascular agonists. Can J Physiol Pharmacol 72:1075-1085.
20. Leach RM, Sheehan DW, Chacko VP, and Sylvester JT (1998) Effects of hypoxia on energy state and pH in resting pulmonary and femoral arterial smooth muscles. Am J Physiol 275: L1051-L1060.
21. Lee KM, Tsai KY, Wang N, and Ingber DE (1998) Extracellular matrix and pulmonary hypertension: Control of vascular smooth muscle cell contractility. Am J Physiol 274:H76-H82.
22. Levine RL (1993) Ischaemia: From acidosis to oxidation. FASEB J 7:1242-1246.
23. Levitzki A and Gazit A (1995) Tyrosine kinase inhibition: An approach to drug development. Science (Wash DC) 267:1782-1788.
24. i in porcine coronary artery smooth muscle. Circ Res 75:990-998.
25. 1 receptor antagonist KW-3902 prevents hypoxia-induced renal vasoconstriction. J Pharmacol Exp Ther 291:988-993.
26. Okada T, Kawano Y, Sakakibara T, Hazeki O, and Ui M (1994) Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilypolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J Biol Chem 269:3568-3573.
27. Quignard JF, Mironneau J, Carricaburu V, Fournier B, Babich A, Niirnbergs B, Mironneau C, and Marcrez N (2001) Phosphoinositide 3-kinase γ mediates angiotensin II-induced stimulation of L-type calcium channels in vascular myocytes. J Biol Chem 276:32545-32551.
28. Somlyo AP and Sonilyo AV (1998) From pharmacomechanical coupling to G-proteins and myosin phosphatase. Acta Physiol Scan 164:437-448.
29. Smith GL, Austin C, Crichton C, and Wray S (1998) A review of the actions and control of intracellular pH in vascular smooth muscle. Cardiovasc Res 38:316-331.
30. Vlahos C, Matter WF, Hui KY, and Brown RF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269:5241-5248.
31. Watts SW, Yeum CH, Campbell G, and Webb RC (1996) Serotonin stimulates protein tyrosyl phosphorylation and vascular contraction via tyrosine kinase. J Vasc Res 33:288-298.
32. Wijetunge S, Aalkjaer C, Schachter M, and Hughes AD (1992) Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun 189:1620-1623.
33. Wijetunge S, Lymn JS, and Hughes AD (1998) Effect of inhibition of tyrosine phosphatases on voltage-operated calcium channel currents in rabbit isolated ear artery cells. Br J Pharmacol 124:307-316.
34. Wu H and Parsons JT (1993) Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol 120:1417-1426.
35. 3-kinases and MAPK signaling pathways. Pfluegers Arch 439:240-247.
36. o induces contraction of cerebral arteries: Roles of tyrosine and mitogen-activated protein kinases. Am J Physiol 279:H185-H194.
37. i in canine cerebral arterial smooth muscle: Participation of cellular signaling pathways. Naunyn-Schmiedeberg's Arch Pharmacol 360:646-653.